Latest News
Transcranial Direct Current Stimulation May Provoke Anxiety Response
Telepsychiatry for Asylum Seekers May be Effective, Improve Access
Association Between Nitrogen Dioxide and Schizophrenia Only Slightly Confounded
Concomitant Esketamine Nasal Spray Did Not Significantly Improve Depression Symptoms in Older Adults
Weill Cornell Medicine Hosts First-Ever Symposium on Mental Health in Medical Students
Time Spent in United States Linked to Opioid Use Among Immigrants
Inappropriate Antipsychotics Raise Pneumonia Risk in Older Adults With Parkinson Disease
Cannabis Use Disorder Tied to Arrhythmia Hospitalization
Commercial Insurance Plans Produce Disproportionately High Out-of-Network Costs for Mental Healthcare
Mindfulness-Based Stress Reduction Shows Benefits for Veterans With PTSD
Exercise Mitigates Risk for Depression, Even With Genetic Risk
Anterior Hippocampal Hyperactivity Observed in Early Psychosis
Youth More Vulnerable to Seasonal Depression Symptoms
Psychosocial Adversity in Children of Undocumented Parents
2007 to 2016 Saw Increase in Child Psychiatrists in US
Inflammatory Response to Stress May Predict CBT Response in Youth With Mood Disorders
The p Factor: A General Dimension of Childhood Psychopathology to Predict Psychiatric Disorders in Adulthood?
Predicting Sex-Specific Suicide Risk Using Machine Learning Models
How Does a Visual Construction of the World Influence Psychosis?
Latest Features
How I Treat Adult Schizophrenia With Paliperidone
Asim Shah, MD, and Syed Z. Iqbal, MD, discuss the use of paliperidone to treat adult patients with schizophrenia.
Is Placebo Use Questionable in Schizophrenia Relapse Studies?
Researchers weigh in on the use of placebo-controlled trials in schizophrenia.
Changes in Appetite and Inflammation in Major Depressive Disorder
Investigators found data that showed a ghrelinergic signaling mechanism may be responsible for increased appetite in patients with MDD.
A New Center at Johns Hopkins Builds the Case for Psychedelic Research
A newly established center at Johns Hopkins is reinvigorating research on the potential therapeutic applications of psychedelics.
Off-Label Use of Antidepressants for Chronic Pain
Depression is a common comorbidity among patients with chronic pain, and the use of antidepressants may alleviate symptoms of both disorders.
